Long-Term Liabilities to Equity: sintx.com (SINT)

Official company branding of Sintx Technologies, Inc. (SINT)

Ceramic production for implants is low-cyclical and crisis-resistant. The long-term debt-to-equity ratio demonstrates the current financial leverage, where 0.51 represents the current level of the metric. Risks are associated with low liquidity and operating losses. However, the impeccable reputation of Sintx Technologies (SINT) in creating biocompatible materials guarantees surgeon trust and stable demand.

sintx.com (SINT): Long-Term Debt to Capital from 07/04/2022 to 10/28/2026
Core merchandise of Sintx Technologies Inc

To identify stability drivers, investors must evaluate the financing structure. This metric is calculated as the ratio of loans with a maturity exceeding one year to equity. By analyzing the level of long-term liabilities relative to equity, one can determine the issuer's degree of financial autonomy. For Sintx Technologies (SINT), this balance is critical when competing with materials science behemoths. A low debt load will ensure the company's survival amid pricing pressure.

Direct competitors

Ratio of Long-Term Indebtedness to Capital BSX|EW - Long-Term Debt to Equity|Long-Term Liabilities to Equity ResMed Corporation (RMD)|PODD: Long-Term Debt to Capital|Long-Term Liabilities to Capital Zimmer ZBH|COO: Long-Term Debt to Capital|ALGN - Long-Term Debt to Equity Ratio|Globus Medical Corp - Long-Term Debt to Capital|TransMedics Group, Inc. (TMDX) - Ratio of Long-Term Indebtedness to Capital|ATEC (Alphatec Holdings, Inc.) - Long-Term Debt to Capital|Long-Term Debt to Capital AORT|Long-Term Debt to Equity Enovis (ENOV)|Long-Term Debt to Equity Integra LifeSciences Corp (IART)|Long-Term Debt to Capital ESTA|BBNX - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Ratio IRADIMED CORPORATION|EMBC - Long-Term Liabilities to Equity|Long-Term Debt to Capital TNDM|AxoGen Inc (AXGN) - Long-Term Liabilities to Capital|Long-Term Debt to Capital SI-BONE Corp (SIBN)|Long-Term Debt to Capital Ratio Orthofix Corp (OFIX)|Bioventus Inc. (BVS) - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Coefficient KIDS (orthopediatrics.com)|Treace Medical Concepts, Inc. - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio Blade Air Mobility SRTA|CARL (Carlsmed Corp) - Long-Term Debt to Capital|RXST - Long-Term Liabilities to Capital|Long-Term Debt to Capital clearpointneuro.com|stereotaxis.com (STXS) - Long-Term Debt to Capital Ratio|STIM: Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital Sight Sciences Inc.|Long-Term Debt to Capital OBIO (Orchestra BioMed)|Long-Term Debt to Equity Ratio anikatherapeutics.com (ANIK)|Long-Term Debt to Capital NSPR (InspireMD, Inc.)|Jin Medical International Ltd. - Long-Term Debt to Capital|VANI - Long-Term Debt to Equity|Xtant Medical Holdings (XTNT) - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio NeuroOne Corp NMTC|Modular Medical, Inc. (MODD) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital MYO (Myomo, Inc.)|Long-Term Liabilities to Capital COCH|VVOS: Long-Term Debt to Equity|Long-Term Indebtedness to Equity enVVeno Medical Corporation NVNO|Long-Term Debt to Equity Ratio TNON (Tenon Medical, Inc)|Long-Term Debt to Capital Lifeward Ltd. LFWD|Long-Term Debt to Capital AMIX (Autonomix)|IVF: Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Bone Biologics Corp (BBLG)|AXNX (Axonics Inc.) - Long-Term Liabilities to Equity|Long-Term Debt to Equity BIOL|Long-Term Debt to Equity Ratio Dynatronics Corp.|Paragon 28, Inc. - Long-Term Debt to Capital|Long-Term Liabilities to Capital INVO (invobioscience.com)